Siegfried Reich Turning Point Therapeutics, Inc. (TPTX) insider trading activity

TPTX Quotes by TradingView

Siegfried Reich is EVP & Chief Scientific Officer of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 3,448 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Feb 09, 2022, when has been sold 397 shares (Common Stock) at a price of $36.3 per share, resulting in proceeds of $14,411. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.45K
0% 3M change
0% 12M change
Total Value Held $0

Siegfried Reich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2022
SELL
Open market or private sale
$14,411 $36.3 p/Share
397 Reduced 10.33%
3,448 Common Stock
Feb 09 2022
BUY
Grant, award, or other acquisition
-
13,567 Added 44.36%
17,015 Common Stock
Mar 04 2021
SELL
Open market or private sale
$3,786,786 $106.52 p/Share
35,550 Reduced 90.24%
3,845 Common Stock
Mar 04 2021
BUY
Exercise of conversion of derivative security
$1,823,004 $51.28 p/Share
35,550 Added 47.43%
39,395 Common Stock
Feb 08 2021
BUY
Grant, award, or other acquisition
-
3,845 Added 50.0%
3,845 Common Stock
SR

Siegfried Reich

EVP & Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPTX